Callan JMB Advances U.S. Pharmaceutical Manufacturing at the Atlas Complex and Expands into North American Equipment Distribution and Assembly
Key Highlights
- ➤$28 million in TRUKING equipment planned for Atlas pharmaceutical manufacturing
- ➤$500,000 down payment expected under Callan JMB’s initial equipment purchase order
- ➤Callan JMB to distribute and assemble TRUKING equipment across North America
- ➤90,000-square-foot Marion 9 facility targets initial production before end-2027
- ➤TRUKING will fabricate equipment in China for shipment and installation in Alabama
Expert Statements
Wayne Williams, Chief Executive Officer of Callan JMB
“Our work in preparedness and response has always depended on knowing how to source critical products, protect their integrity, and get them where they are needed”
Wayne Williams, Chief Executive Officer of Callan JMB
“Developing pharmaceutical manufacturing at the Atlas Complex extends that experience further into the supply chain.”
Wayne Williams, Chief Executive Officer of Callan JMB
“By connecting U.S. production with our logistics and distribution capabilities, we aim to strengthen the availability of essential products before an emergency and support resupply when demand increases.”
Wayne Williams, Chief Executive Officer of Callan JMB
“Our role with TRUKING also creates an opportunity to support additional manufacturing projects and commercial customers.”
Approximately $28 million in planned TRUKING equipment advances domestic manufacturing capacity, strengthens the Company’s preparedness strategy, and supports new commercial opportunities
SPRING BRANCH, Texas, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), a diversified preparedness, logistics, and critical-infrastructure company, today announced progress toward establishing domestic pharmaceutical manufacturing at the Atlas Complex in Marion, Alabama, through an equipment procurement and distribution collaboration with TRUKING. The Company has signed an initial purchase order and expects to make a $500,000 down payment toward approximately $28 million in pharmaceutical manufacturing equipment planned for installation at Atlas.
Get started
Create a free account to read the full story.